Advertisement

Topics

"Low-Dose IL-2 Plus IFN-Alpha Immunotherapy as Adjuvant Treatment of Renal Carcinoma." Drugs and Medication Database

00:36 EST 21st February 2019 | BioPortfolio

Here are the most relevant "Low-Dose IL-2 Plus IFN-Alpha Immunotherapy as Adjuvant Treatment of Renal Carcinoma." Drugs and Medications that we have found in our database.

More Information about "Low-Dose IL-2 Plus IFN-Alpha Immunotherapy as Adjuvant Treatment of Renal Carcinoma." on BioPortfolio

We have published hundreds of Low-Dose IL-2 Plus IFN-Alpha Immunotherapy as Adjuvant Treatment of Renal Carcinoma. news stories on BioPortfolio along with dozens of Low-Dose IL-2 Plus IFN-Alpha Immunotherapy as Adjuvant Treatment of Renal Carcinoma. Clinical Trials and PubMed Articles about Low-Dose IL-2 Plus IFN-Alpha Immunotherapy as Adjuvant Treatment of Renal Carcinoma. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Low-Dose IL-2 Plus IFN-Alpha Immunotherapy as Adjuvant Treatment of Renal Carcinoma. Companies in our database. You can also find out about relevant Low-Dose IL-2 Plus IFN-Alpha Immunotherapy as Adjuvant Treatment of Renal Carcinoma. Drugs and Medications on this site too.

Showing "Dose Plus Alpha Immunotherapy Adjuvant Treatment Renal Carcinoma" Drugs and Medications 1–25 of 431

Probably Relevant

Letrozole [breckenridge pharmaceutical, inc.]

These highlights do not include all the information needed to use LETROZOLE TABLETS safely and effectively. See full prescribing information for LETROZOLE TABLETS. LETROZOLE tablets, for oral use Initial U.S. Approval: 1997

Letrozole [sun pharmaceutical industries limited ]

These highlights do not include all the information needed to use LETROZOLE TABLETS safely and effectively. See full prescribing information for LETROZOLE TABLETS. LETROZOLE tablets, for oral use Initial U.S. Approval: 1997

Letrozole [apotex corp.]

These highlights do not include all the information needed to use LETROZOLE TABLETS safely and effectively.See full prescribing information for LETROZOLE TABLETS. LETROZOLE tablets, for oral use Initial U.S. Approval: 1997

Letrozole [west-ward pharmaceuticals corp.]

These highlights do not include all the information needed to use LETROZOLE TABLETS safely and effectively. See full prescribing information for LETROZOLE TABLETS.LETROZOLE tablets, for oral use Initial U.S. Approval: 1997

Letrozole [accord healthcare, inc.]

These highlights do not include all the information needed to use letrozole tablets safely and effectively. See full prescribing information for letrozole tablets. LETROZOLE tablets, for oral use Initial U.S. Approval: 1997

Letrozole [bryant ranch prepack]

These highlights do not include all the information needed to use letrozole tablets safely and effectively. See full prescribing information for letrozole tablets. LETROZOLE tablets, for oral use Initial U.S. Approval: 1997

Letrozole [aurobindo pharma limited]

These highlights do not include all the information needed to use LETROZOLE TABLETS safely and effectively. See full prescribing information for LETROZOLE TABLETS. LETROZOLE tablets, for oral use Initial U.S. Approval: 1997

Letrozole [jiangsu hengrui medicine co., ltd.]

These highlights do not include all the information needed to use LETROZOLE TABLETS safely and effectively. See full prescribing information for LETROZOLE TABLETS. LETROZOLE tablets, for oral use Initial U.S. Approval: 1997

Femara [novartis pharmaceuticals corporation]

These highlights do not include all the information needed to use FEMARA safely and effectively. See full prescribing information for FEMARA. Femara (letrozole) tablets, for oral use Initial U.S. Approval: 1997

Letrozole [arab pharmaceutical manufacturing co. psc ltd]

      These highlights do not include all the information needed to use LETROZOLE TABLETS   safely and effectively. See full prescribing information for LETROZOLE TABLETS       LETROZOLE tablets , for oral use. Initial U.S. Approval:   1997  

Letrozole [dr. reddy's laboratories limited]

These highlights do not include all the information needed to use Letrozole safely and effectively. See full prescribing information for Letrozole Letrozole Tablets USP Initial U.S. Approval: 1997  

Letrozole [indicus pharma llc]

These highlights do not include all the information needed to use letrozole tablets safely and effectively. See full prescribing information for letrozole tablets. letrozole tablets USP ,2.5 mg Initial U.S. Approval: 1997

Letrozole [american health packaging]

These highlights do not include all the information needed to use Letrozole Tablets, USP safely and effectively. See full prescribing information for Letrozole Tablets, USP. LETROZOLE Tablets, USP for oral use Initial U.S. Approval: 1997

Femara [physicians total care, inc.]

These highlights do not include all the information needed to use Femara safely and effectively. See full prescribing information for Femara. Femara (letrozole ) ta blets Initial U.S. Approval: 1997

Letrozole [a-s medication solutions]

These highlights do not include all the information needed to use letrozole tablets safely and effectively. See full prescribing information for letrozole tablets. LETROZOLE tablets USP, for oral use Initial U.S. Approval: 1997

Sylatron [merck sharp & dohme corp.]

These highlights do not include all the information needed to use SYLATRON safely and effectively. See full prescribing information for SYLATRON. SYLATRON™ (peginterferon alfa-2b) for injection, for subcutaneous use Initial U.S. Approval: 2011

Sutent [pfizer laboratories div pfizer inc]

These highlights do not include all the information needed to use SUTENT safely and effectively. See full prescribing information for SUTENT. SUTENT (sunitinib malate) capsules, for oral useInitial U.S. Approval: 2006

Possibly Relevant

Mvasi [amgen inc]

These highlights do not include all the information needed to use MVASI safely and effectively. See full prescribing information for MVASI .     MVASI (bevacizumab-awwb ) Solution for intravenous infusion Initial U.S. Approval: 2017 MVASI (bevacizumab-

Gemcitabine hydrochloride [bluepoint laboratories]

These highlights do not include all the information needed to use Gemcitabine for Injection safely and effectively. See full prescribing information for Gemcitabine for Injection. Gemcitabine for injection, Powder, Lyophilized, For Solution For Intravenou

Halaven [eisai inc.]

These highlights do not include all the information needed to use HALAVEN safely and effectively. See full prescribing information for HALAVEN.         HALAVEN (eribulin mesylate) injection, for intravenous use Initial U.S. Approval: 2010

Gemcitabine [hospira, inc.]

These highlights do not include all the information needed to use GEMCITABINE FOR INJECTION safely and effectively. See full prescribing information for GEMCITABINE FOR INJECTION.GEMCITABINE for injection, powder, lyophilized, for solution for intravenous

Gemcitabine [hospira, inc.]

These highlights do not include all the information needed to use GEMCITABINE FOR INJECTION safely and effectively. See full prescribing information for GEMCITABINE FOR INJECTION. GEMCITABINE for injection, powder, lyophilized, for solution for intravenou

Gemcitabine [fresenius kabi usa, llc]

These highlights do not include all the information needed to use GEMCITABINE FOR INJECTION, USP safely and effectively. See full prescribing information for GEMCITABINE FOR INJECTION, USP. GEMCITABINE FOR INJECTION, USP, Powder, Lyophilized, For Solution

Gemcitabine [fresenius kabi usa, llc]

These highlights do not include all the information needed to use Gemcitabine for Injection, USP safely and effectively. See full prescribing information for Gemcitabine for Injection, USP. Gemcitabine for Injection, USP, Powder, Lyophilized, For Solution

Gemcitabine hydrochloride [cipla usa inc.]

These highlights do not include all the information needed to use GEMCITABINE FOR INJECTION safely and effectively. See full prescribing information for GEMCITABINE FOR INJECTION. GEMCITABINE for injection, for intravenous useInitial U.S. Approval: 1996



Advertisement
Quick Search
Advertisement
Advertisement